Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17130430.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is not known whether the antiepileptic drug (AED) levetiracetam can be used safely in human pregnancy. As part of a study to determine the risks of major congenital malformations (MCMs) for infants exposed to AEDs in utero, we identified all cases exposed to levetiracetam. Three of 117 exposed pregnancies had an MCM (2.7%; 95% CI 0.9% to 7.7%); all 3 were exposed to other AEDs.
Medical subject headings
- Abnormalities, Drug-Induced
- Anticonvulsants
- Piracetam
- Prenatal Exposure Delayed Effects